CDMO 241220 12.50P (CDMO241220P12500) Stock Options, News & Quotes

0.49
0.000.00%

15min DelayClose Nov 22 11:37 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

MARKET-TEST-DUMMY

Jul 4 05:44

Hmm

$Avid Bioservices (CDMO.US)$

Moomoo AI

Feb 8 04:32

Investors' belief in Societal CDMO's lackluster revenue performance not improving may be causing its low P/S ratio. The company's inferior revenue outlook compared to the industry average contributes to this. A significant change in fortune is needed to justify a higher P/S.

Societal CDMO, Inc.'s (NASDAQ:SCTL) Shares Bounce 29% But Its Business Still Trails The Industry

Moomoo AI

Jan 26 05:03

The company's high debt and lack of profitability strain its balance sheet. Negative free cash flow adds risk, but its US$417.4m market cap could potentially allow capital raising to strengthen the balance sheet.

We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt

Moomoo AI

Dec 18, 2023 11:16

Investors' belief in Avid Bioservices' stagnant revenue performance and future growth lagging behind the industry has led to its low P/S. The underwhelming revenue outlook and shareholders' pessimism impact the P/S negatively.

Avid Bioservices, Inc.'s (NASDAQ:CDMO) Revenues Are Not Doing Enough For Some Investors

Moomoo AI

Nov 10, 2023 04:56

Despite good revenue growth, the market expected more, as seen in the share price drop. This could hint at delayed revenue growth. The recent sell-off might be an investment chance considering the signs of a continued growth trend.

Further Weakness as Avid Bioservices (NASDAQ:CDMO) Drops 19% This Week, Taking One-year Losses to 66%